XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Net revenue        
Total net revenue $ 4,481 $ 3,294 $ 11,916 $ 10,981
Cost of net revenue 2,445 2,000 7,346 6,747
Gross profit 2,036 1,294 4,570 4,234
Operating expenses        
Research and development 3,484 4,509 11,038 15,636
Selling, general and administrative 2,112 3,353 6,331 8,938
Gain on license and asset sale (2,557) (406) (2,557)
Total operating expenses 5,596 5,305 16,963 22,017
Loss from operations (3,560) (4,011) (12,393) (17,783)
Change in fair value of warrant liabilities 2,615 4,239
Other income/(expense), net 322 3 297 (22)
Net loss (623) (4,008) (7,857) (17,805)
Other comprehensive loss, net of tax:        
Net unrealized gain (loss) on available-for-sale securities 4 5 25 (36)
Comprehensive loss $ (619) $ (4,003) $ (7,832) $ (17,841)
Net loss per share        
Net loss per share, basic (in Dollars per share) $ (0.02) $ (0.2) $ (0.32) $ (0.89)
Shares used in computing net loss per share        
Shares used in computing net loss per share, basic (in Shares) 28,589 20,039 24,892 19,950
Product        
Net revenue        
Total net revenue $ 4,262 $ 3,060 $ 11,385 $ 10,384
Royalty and Other        
Net revenue        
Total net revenue $ 219 $ 234 $ 531 $ 597